ARWR - 3.33 Pre-market now at 3.35/3.68 Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy http://stockcharts.com/c-sc/sc?s=ARWR&p=D&b=5&g=0&i=t25874458000&r=1512563445101 http://stockcharts.com/c-sc/sc?s=ARWR&p=W&b=5&g=0&i=t14949316085&r=1512563429218